| P50 | author | Simon Lovestone | Q30582986 |
| | Cristina Cereda | Q37842077 |
| | Steven J Kiddle | Q38546499 |
| | Malcolm A Ward | Q40398264 |
| | John F Graf | Q47149188 |
| | Mizanur Khondoker | Q47163880 |
| | Sarah Westwood | Q57012921 |
| | Abdul Hye | Q57012954 |
| | Steven Lynham | Q57334686 |
| | Nicholas J Ashton | Q58826163 |
| P2093 | author name string | David Baker | |
| | Madhav Thambisetty | |
| | Emanuela Leoni | |
| | Cristina Tan Hehir | |
| | Alison L Baird | |
| | Chantal Bazenet | |
| | Ricardo Sainz-Fuertes | |
| | Rufina Leung | |
| P2860 | cites work | Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 |
| | Plasma biomarkers of brain atrophy in Alzheimer's disease | Q28741028 |
| | Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease | Q30495250 |
| | The A4 study: stopping AD before symptoms begin? | Q33725775 |
| | APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging | Q33796980 |
| | Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model | Q33810933 |
| | Alzheimer's disease drug-development pipeline: few candidates, frequent failures | Q33892815 |
| | Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease | Q34157492 |
| | A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study | Q34341870 |
| | Plasma based markers of [11C] PiB-PET brain amyloid burden | Q34427001 |
| | Plasma proteins predict conversion to dementia from prodromal disease | Q34556953 |
| | Proteome-based plasma biomarkers for Alzheimer's disease | Q34577503 |
| | Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals | Q35076119 |
| | Blood-brain barrier breakdown in the aging human hippocampus | Q35151019 |
| | A blood-based algorithm for the detection of Alzheimer's disease | Q35203409 |
| | A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain | Q35841946 |
| | Blood protein predictors of brain amyloid for enrichment in clinical trials? | Q36926754 |
| | Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern? | Q36942803 |
| | Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology | Q37044150 |
| | Fibrinogen and altered hemostasis in Alzheimer's disease | Q38032520 |
| | Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study | Q38152257 |
| | The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease | Q39976878 |
| | Cell replication and aging: in vitro and in vivo studies | Q41492833 |
| | Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging | Q43062420 |
| | Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease | Q44191043 |
| | The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study | Q44464567 |
| | Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease | Q46155330 |
| | Blood-based protein biomarkers for diagnosis of Alzheimer disease | Q47378944 |
| | Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain | Q47950183 |
| | Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice. | Q51431393 |
| | Age-related differences in lactate distribution kinetics following maximal exercise | Q66959606 |
| | Activities and attitudes of participants in the Baltimore longitudinal study | Q72798056 |
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 561-572 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly | |
| P478 | volume | 52 | |